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Abstract 
 
Introduction: Human Papillomavirus (HPV) is the most common sexually transmitted 
infection with an estimated fourteen million new cases each year in the United States 
alone. HPV infections generally resolve with little or no incident, but persistent infections 
can lead to more serious sequelae such as oral and cervical cancers. The Centers for 
Disease Control and Prevention recommends that all 11-12 year olds receive the HPV 
vaccine; yet, the prevalence of HPV vaccination in the U.S. population is far below the 
prevalence of routine childhood vaccinations. Clearly, there is a public health imperative 
to increase the HPV vaccination rate among American youth. Because orthodontists see 
patients of the vaccination target age monthly, for 2 or more years, they are particularly 
well positioned to influence vaccination rates by educating patients and their parents 
about HPV and the HPV vaccine. Therefore, the goals of this study were to examine the 
determinants of orthodontists’ willingness to provide an HPV educational intervention to 
adolescent patients, and orthodontists’ agreement that HPV is within the scope of 
orthodontic practice. Methods: A survey instrument informed by the Integrated Behavior 
	 vii	
Model of health behaviors was used to obtain cross-sectional data from a representative 
sample of Florida Orthodontists’ that assessed personal and practice demographics, 
knowledge regarding HPV and the HPV vaccine, and their willingness to provide an 
HPV educational intervention. Univariate, bivariate, principle component, and 
multivariable logistic regression analyses were used to evaluate the specific aims. 
Results: For each year that participants’ aged, the adjusted odds of willingness increased 
12% (AOR = 1.12, 95% CI 1.02, 1.23). Additionally, those participants who agreed that 
HPV causes cancer in females, were four times more willing to provide an HPV 
educational intervention than those who disagreed (AOR = 4.07, 95% CI 1.51, 10.94). 
Perceived Control (AOR = 2.03, 95% CI 1.06, 3.90), and Salience (AOR = 3.09, 95% CI 
1.35, 7.09) were also significant determinants of orthodontists’ willingness to provide an 
HPV educational intervention. The amount of office time respondents were willing to 
provide to deliver HPV information to patients was a significant predictor of agreement 
that HPV was within the scope of orthodontic practice; less than 1 minute (AOR = 7.55, 
95% CI 1.09, 52.33), 1-2 minutes (AOR = 21.20, 95% CI 3.44, 130.52), and 3-4 minutes 
(AOR = 41.05, 95% CI 6.04, 279.12). Neither self-rated knowledge nor agreement that 
HPV is within the scope of orthodontic practice, were significant determinants of 
orthodontists’ willingness to provide an HPV educational intervention. In addition, 
encouragement to discuss HPV or recommend the HPV vaccine during professional 
education were not significant predictors of respondents’ agreement that HPV is within 
the scope of orthodontic practice. Conclusions: Our findings suggest an opportunity to 
impact orthodontists’ willingness to provide an HPV educational intervention through 
encouraging orthodontists to discuss HPV and the HPV vaccine effectively in 
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professional school and continuing education, the availability and dissemination of 
informational pamphlets, and support and guidance from the American Association of 
Orthodontists (AAO). Also, support and guidance from the AAO may promote 
orthodontists’ understanding that HPV is within the scope of orthodontic practice. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 ix	
Table of Contents 
 
Acknowledgement .............................................................................................................v 
Abstract .............................................................................................................................vi 
Table of Contents .............................................................................................................ix 
List of Tables ....................................................................................................................xi 
List of Figures .................................................................................................................xii 
Chapter 1: Introduction ...................................................................................................1 
 
1.1. Background ........................................................................................................................1 
1.1.1. The Human Papillomavirus ......................................................................................1 
1.1.2. Human Papillomavirus - Microbiology & Pathogenesis ..........................................2 
1.1.3. Human Papillomavirus - Vaccination and Guidelines ..............................................3 
1.1.4. Human Papillomavirus - Vaccine Safety and Efficacy .............................................4 
     1.2. Human Papillomavirus Health Impact ............................................................................6 
1.2.1. Low Vaccination Rates .............................................................................................6 
1.2.2. Potential Facilitators and Barriers .............................................................................7 
1.2.3. The Orthodontists’ Impact ........................................................................................8 
     1.3. Models of Behavior ............................................................................................................9 
1.3.1. History and Background - Psychological Health Behavior Models........................10 
1.3.2. The Integrated Behavior Model ..............................................................................12 
     1.4. Current Study ...................................................................................................................14 
1.4.1. Purpose ....................................................................................................................14 
1.4.2. Specific Aims/Hypotheses ......................................................................................15 
 
Chapter 2: Materials and Methods ...............................................................................16 
      
2.1. Study ..................................................................................................................................16 
     2.2. Participants .......................................................................................................................16 
     2.3. Focus Group Procedures .................................................................................................17 
     2.4. Survey Instrument ...........................................................................................................18 
     2.5. Solicitation and Recruitment ..........................................................................................19 
     2.6. Dependent Variables ........................................................................................................22 
     2.7. Independent Variables .....................................................................................................23 
     2.8. Statistical Analysis ...........................................................................................................24 
 
Chapter 3: Results ...........................................................................................................27 
 
3.1. Participation Summary ...................................................................................................27 
     3.2. Descriptive Statistics ........................................................................................................27 
     3.3. Principle Component Analysis – Factor Loading .........................................................30 
     3.4. Multivariable Logistic Regression ..................................................................................32 
	 x	
3.4.1. Willingness to Provide an HPV Educational Intervention .....................................33 
3.4.2. Agreement HPV is Within the Scope of Orthodontic Practice …...........................34 
 
Chapter 4: Discussion .....................................................................................................36 
 
Chapter 5: Conclusions ..................................................................................................45 
      
5.1. Strengths and Limitations ...............................................................................................45 
     5.2. Future Studies ..................................................................................................................46 
 
Appendices 
 
Appendix A 
Table 1 .............................................................................................................................48 
Appendix B 
Table 2 .............................................................................................................................56 
Appendix C 
Table 3 .............................................................................................................................58 
Appendix D 
Table 4 .............................................................................................................................60 
Appendix E 
Focus Group Interview Questionnaire ........................................................................62 
Appendix F 
Informed Consent ...........................................................................................................65 
Appendix G 
Survey Instrument ..........................................................................................................68 
 
Bibliography ....................................................................................................................77 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 xi	
List of Tables (Appendix A – Appendix D) 
 
 
Table 1. Descriptive Characteristics – Characteristics of orthodontist participants 
currently practicing in the state of Florida ……………………….............Appendix A - 48 
 
Table 2. Principal Component Analysis – Factor Loading .......................Appendix B - 55 
 
Table 3. Multivariable logistic regression analysis of Florida Orthodontists’ willingness 
to provide an HPV educational intervention ..............................................Appendix C - 58 
 
Table 4. Multivariable logistic regression analysis of Florida Orthodontists’ agreement 
that HPV is within the scope of orthodontic practice …............................Appendix D - 60 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 xii	
List of Figures 
 
Figure 1. Theory of Reasoned Action and Theory of Planned Behavior Flowchart .......12 
 
Figure 2. Integrated Behavior Model Flowchart ..............................................................14 
 
Figure 3. Sample Frame Breakdown ………....................................................................17 
 
Figure 4. Power Calculation for Multiple Logistic Regression Analysis …...………….26 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 1	
Chapter 1: Introduction  
 
1.1. Background 
 
1.1.1. The Human Papillomavirus  
 
Human Papillomavirus (HPV) is the most common sexually transmitted virus that 
infects most men and women at some point in their lives.1 It is estimated that there are 
more than fourteen million new cases of HPV each year in the United States.1 While most 
infections resolve spontaneously, HPV can cause a number of health sequelae that range 
from benign warts to invasive cancers.1,2 HPV plays a prominent role in the development 
of cervical cancer, the second most prevalent cancer among women.3 The incidence and 
prevalence of different HPV-related cancers vary by sex and race/ethnicity. The United 
States Centers for Disease Control and Prevention (CDC) cancer registry data reveals a 
higher incidence of HPV-related cervical cancers among black and Hispanic women than 
women of other race/ethnicities.4 Similarly, the incidence of HPV-related vaginal cancers 
are greater in Black and Hispanic women than others, while white women exhibit a 
higher incidence of HPV-related vulvar cancers.4  
 
HPV is particularly pertinent for oral health professionals because it has been 
identified as an etiologic agent for oropharyngeal cancers.5 A case study in the United 
States that examined 130 individuals with newly diagnosed oropharyngeal cancers found 
that 63% were attributable to HPV infection.6,7 As with HPV-associated genital tract 
cancers, studies have also demonstrated that the incidence and prevalence of HPV-related 
oropharyngeal cancers vary by race/ethnicity and sex. Higher incidence of HPV-related 
oropharyngeal cancers exist among non-Hispanic whites compared to Hispanics and non-
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Hispanic blacks. Moreover, the incidence of HPV-related oropharyngeal cancers is higher 
for men than for women.4 According to the CDC, between 2008 and 2012, approximately 
1:10,000 males and 1:50,000 females were diagnosed with an HPV-associated 
oropharyngeal cancer in the state of Florida alone.8 These statistics are particularly 
discouraging considering that preventative vaccines have been available since 2006.1 
 	
1.1.2. The Human Papillomavirus - Microbiology & Pathogenesis  	
The Human Papillomavirus is composed of small, circular, non-enveloped double 
stranded DNA that infects both cutaneous and mucosal epithelium.2,9 There are over 200 
strains of the HPV virus that are each differentiated by a genetic sequence found in their 
outer protein capsule.2,9 HPV viruses are further categorized by morbidity / oncogenicity, 
as either low-risk / non-oncogenic, or high-risk / oncogenic.2 The non-oncogenic strains 
include HPV-6 and HPV-11 and have been implicated in benign lesions such as genital 
warts, while oncogenic strains include HPV-16 and HPV-18 and have been identified as 
etiologic agents for cervical and oropharyngeal cancers.2 Specifically, HPV-16 is the 
cause of approximately 50% of cervical cancers worldwide, and HPV-16 and HPV-18 
together account for about 70% of cervical cancers.10 Likewise, 90% of HPV-positive 
oropharyngeal cancers are associated with HPV-16 and HPV-18.6,11-14 Oncogenic strains 
of the HPV virus integrate into the host’s genome and produce oncoproteins that in turn 
target and destroy tumor suppressor genes TP53 and RB1 that allow the virus to 
proliferate.15  
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Transmission of the virus is predominantly through skin-to-skin contact with an 
infected individual.1 Infected individuals most commonly transmit the HPV virus through 
vaginal or anal sexual intercourse; however, it is also transmitted through oral sex and 
open-mouth kissing.1,16 The virus is latent in most people, producing no clinical signs of 
infection. In such cases, the virus is usually cleared by host immune response in six to 
twenty-four months.1,9,15 A small percentage of individuals do become symptomatic.15 
Genital warts are the most common clinical manifestation of the HPV virus and occur in 
1% of the sexually active U.S. population. Other clinical manifestations of the HPV virus 
include anal warts, recurrent respiratory papillomatosis, cervical intraepithelial neoplasia, 
and more serious malignancies including vaginal, cervical, penile, anal, and 
oropharyngeal cancer.2 
 
 
1.1.3. The Human Papillomavirus – Vaccinations and Guidelines  
 
There is no treatment for existing HPV infections; however, The United States 
Food and Drug Administration (FDA) has approved three vaccines that can prevent 
infection of several oncogenic HPV strains. Cervarix is a bivalent intramuscularly 
administered vaccine, indicated for females, that evokes an immune response against 
HPV-16 and HPV-18.17 The Cervarix regimen involves three doses; the second dose one 
month and third dose six months following the initial dose.17 Gardasil, is a quadrivalent 
vaccine that protects against HPV strains 6, 11, 16, and 18.9 Gardasil, indicated for both 
males and females, is also administered via intramuscular injection.9,18 The Gardasil 
vaccine is also delivered in three doses, following the same regimen as Cervarix.18 
Gardasil 9, a 9-valent vaccine, also indicated for males and females, not only imparts 
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immunity for all HPV strains targeted by Cervarix and Gardasil, but also HPV strains 31, 
33, 45, 52, and 58.1 Gardasil 9 is administered intramuscularly in either a two-dose or 
three-dose regimen.19  
 
The CDC recommends HPV vaccination for males and females between the ages 
of 11-12 years.1 This is the age group when children often begin experimenting sexually 
and are likely exposed to HPV.1 A study by Finer and Philbin concluded that 
approximately 1% of 11-12 year old children engaged in sexual intercourse, however, 
Finer and Philbin did not examine other forms of sexual interaction, such as oral and anal 
sex.20 As such, it is likely that Finer and Philbin’s study underestimated the prevalence of 
sexual activity among 11-12 year old children and by extension, those susceptible to 
exposure. Importantly, studies have shown HPV vaccines are most efficacious if they are 
administered before children become sexually active and not efficacious once they have 
contracted the virus.6  	
 
1.1.4. The Human Papillomavirus Vaccine Safety and Efficacy 
 
Each of the three vaccines recommended by the CDC and approved for use by the 
FDA are safe, when administered with awareness of the contraindications and their 
possible adverse reactions. Contraindications to vaccine administration include allergic 
reactions to vaccine components or a previous HPV vaccine, moderate or severe acute 
illnesses, and pregnancy.2,21 Acute adverse reactions include fever, local cutaneous 
responses at injection sites, such as pain, redness, swelling, and syncope following 
injection.2, 17-19 With respect to long-term adverse reactions, a three-year study evaluated 
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individuals following vaccination with Gardasil and found that with the over 600,000 
doses administered, there were no increased risks of Guillian-Barre Syndrome, stroke, 
venous thromboembolism, appendicitis, syncope, allergic reactions, or anaphylaxis.22  
 
Serious side effects have been reported to rarely occur after HPV vaccination. The 
U.S. Department of Health and Human Services (DHHS) formed The National Vaccine 
Injury Compensation Program (VICP) to address vaccination injuries. The VICP entitles 
seriously injured individuals to compensation.23 The DHHS determines whether the cause 
of the individual’s injury was due to vaccination, by reviewing a petition from the injured 
individual submitted to the VICP.23 After a review of information presented by the 
petitioner and the DHHS, the United States Court of Federal Claims issues a final 
ruling.23 The Health Resources and Services Administration (HRSA), a division of the 
DHHS, reports the frequency of serious complications due to all vaccines, including the 
HPV vaccine.23 From 2006 to 2015, only 13 of the approximately 89,696,704 doses of 
the HPV vaccine that were administered to the U.S. population resulted in injury that lead 
to a financial award to the injured individuals.23 Similarly, 23 of the approximately 
88,814,104 doses of the common childhood vaccination DTaP resulted in injury that lead 
to a financial award to the injured individuals.23 The HPV vaccine seemingly compares 
favorably with the safety observed among the routine DTaP vaccination.  
 
The CDC has deemed HPV vaccines highly efficacious with over 99% of 
recipients developing antibody responses to target genotypes one month after completing 
the appropriate dosing regimen.2 These vaccines provoke an immune response targeted 
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towards particular HPV strains, however, vaccine efficacy is dependent upon whether or 
not the individual was exposed to the specific HPV strains before vaccination. The 
vaccines have no therapeutic effect on pre-existing HPV infections.2 A long-term study 
demonstrated that females vaccinated at ages 10-14 years maintained seropositivity up to 
seven years after immunization with the bivalent HPV vaccine, Cervarix.24 Another 
study, including females and males ages 9-15 years, demonstrated persistent 
seropositivity eight years after immunization with the quadrivalent HPV vaccine, 
Gardasil.25 The seropositivity observed in these studies demonstrated that long-term 
immunogenic response was elicited by both of these HPV vaccines.  
 
 
1.2 The Human Papillomavirus Health Impact 
 
1.2.1. Low Vaccination Rates 
 
The CDC Advisory Committee on Immunization Practices (ACIP) recommends 
that adolescents between the ages of 11-12 years receive routine vaccination for tetanus-
diphtheria-pertussis (DTaP), meningococcal disease, and HPV.26 The ACIP recommends 
the administration of the HPV vaccine together with the DTaP and Meningococcal 
vaccines in a single visit to promote higher HPV vaccination rates, because co-
administration does not negatively impact the immunogenicity of the vaccines.27 Despite 
this recommendation, in 2016 only 49.5% of adolescent females and 37.5% of adolescent 
males had completed the HPV vaccination series, while vaccination coverage of males 
and females aged 13-17 years for ≥1 dose of the DTaP and Meningococcal vaccines were 
88.0% and 82.2%, respectively.26 It is not clear why a disparity in vaccination rates exists 
given that these vaccines are all equally safe and all recommended by the ACIP.  
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1.2.2. Potential Facilitators and Barriers 
To effectively increase HPV vaccination rates in this country, public health 
research must identify the barriers and facilitators that impact vaccine-related discussions 
/ recommendations and vaccine administration. An understanding of these barriers and 
facilitators provide opportunities for targeted public health interventions. In a recent 
study, Gilkey et al.,28  assessed physician communication about adolescent vaccination 
for HPV. 28 Gilkey et al.,28 reported that pediatricians and family physicians viewed 
discussions of HPV vaccination as burdensome, garnering less parental support, and 
lasting twice as long as discussions about other vaccinations.  
 
Educating patients and parents about HPV will likely lead to increased HPV 
vaccination uptake. One study of male students at a two-year college in New York City 
reported that HPV knowledge was low but that acceptability of the vaccine was high.29 
The authors suggested that since individuals are amenable to receiving the vaccine, 
perhaps the low vaccination rates are due to deficiencies in doctor-patient communication 
about HPV.29 The authors speculated that a dialogue between providers and their patients 
to increase HPV awareness, would promote an increase in vaccination rates.29 Similarly, 
Bertram and Niederhauser30 observed that male and female college students in Hawaii 
knew little about HPV or the virus’s relationship to cancer. Their study reported 
confusion among students regarding the differences between high and low risk HPV 
strains and the respective health sequelae.30 Bertram and Niederhauser30 highlighted a 
need for healthcare providers to discuss HPV with their patients to increase patients’ 
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awareness. Clearly, an opportunity exists for all health professionals to play a role in 
HPV education and prevention.  
 
Evidence that HPV causes oral and oropharyngeal cancers highlights the 
important role for dentists in prevention of HPV infection.5,6,9,31 To date, among the small 
number of studies that have focused on HPV provider/patient discussions, fewer have 
considered the potential role of dentists or dental specialists. Among the few studies that 
have considered a role for dentists, Daley et al.,32 found that more than 52% of the 
Florida general dentists surveyed, reported no intention to discuss the HPV vaccine with 
female patients. Daley et al.,32 found that dentists declined to discuss the HPV vaccine 
with patients because of discomfort discussing sexual health related topics, a lack of 
guidelines or oversight from dental professional organizations, and that dialogue 
regarding HPV was viewed as outside the scope of dental practice. As dental specialists, 
orthodontists’ likely share the same aversions to discussing HPV vaccination as their 
general dental colleagues. Yet, it is important to recognize that because the orthodontic 
patient population is predominantly adolescent, efforts by orthodontists to increase HPV 
vaccine rates among their patients may be among the most impactful of all public health 
efforts to increase the HPV vaccination rates. In fact, according to Shapiro,33 an 
orthodontist’s recommendation for HPV vaccination was more important than a 
physician’s recommendation, as a predictor of patients’ parents’ willingness to permit 
their child to receive the HPV vaccine. 
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1.2.3. The Orthodontists’ Impact 
In 2014, 83% of children aged 2-17 years had visited a dentist (including 
specialists such as orthodontists) in the past year.34 As such, dentists are among the most 
frequently visited healthcare providers annually,34 and have an opportunity to provide 
important educational information about HPV and the need to vaccinate that, to date, has 
been overlooked. Given that the majority of orthodontic patients are adolescents, the 
optimal age targeted by the CDC for HPV vaccination, among all dentists, orthodontists 
are perhaps the best positioned to provide important educational information about HPV 
and recommend vaccination. In 2014, American Association of Orthodontists (AAO) 
members in the U.S. and Canada treated a total of 5,419,000 patients.35,36 Seventy-three 
percent (3,959,000) of these patients were 17 years of age or younger.35,36 Patients 
generally visit the orthodontist once per month for two consecutive years. As such, there 
is repeated, frequent contact between orthodontists and their patients. Such contact 
provides opportunities for orthodontists to have discussions with patients, aimed towards 
increasing HPV vaccination uptake. Clearly, orthodontists have a unique opportunity 
and a responsibility to contribute to public health interventions to reduce the prevalence 
of HPV infection and associated cancers that are targeted towards their patients, the 
population most at risk. Yet according to Daley et al.,32 dentists, and likely orthodontists, 
are hesitant to do so. Therefore, it is important to identify the barriers and facilitators 
determining orthodontists’ willingness to discuss HPV with their patients in order to 
capitalize on their potential impactful role in HPV prevention. However, to our 
knowledge, previous studies have not yet examined the determinants of orthodontists’ 
willingness to discuss HPV with patients.  
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1.3 Models of Behavior 
It is important to understand whether orthodontists currently discuss HPV with 
patients and their parents and if not, then it is necessary to examine the determinants of 
their willingness to do so. Psychological models of health behavior are designed to 
explain a wide range of health behaviors by emphasizing that intent is the best predictor 
of performing a behavior.37 The psychological constructs of health behavior models 
permit an understanding of the determinants of behavioral intent that can then be used to 
target and implement effective interventions to change behaviors.37 One such 
psychological model is the Integrated Behavior Model (IBM). The IBM is an extension 
of the Theory of Reasoned Action (TRA) and the Theory of Planned Behavior (TPB).37 
The IBM was used in this study to inform our survey instrument in order to identify the 
determinants of orthodontists’ willingness to provide an HPV educational intervention to 
their patients and agreement that HPV is within the scope of orthodontic practice (Figure 
1). In this context, “educational intervention” was defined as delivery of information 
related to HPV and the HPV vaccine via discussion with patients and parents, delivery of 
instructional videos or pamphlets. 
 
 
1.3.1. History and Background – Psychological Health Behavior Models  
 
The TRA was proposed by Martin Fishbein38 in 1967 and emphasized that the 
best predictor of behavior is behavioral intention. The two constructs Fishbein described 
that influence intention were attitude and subjective norm.38 Attitude is described as a 
person’s overall favorableness or unfavorableness towards performing a behavior and an 
individual’s attitude is a direct determinant of their behavioral intention.38 Fishbein’s 
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second construct, subjective norm, describes how the pressure one feels in social 
interactions influences their intent to perform or not perform a particular behavior.38  
 
The TPB, postulated by Icek Ajzen39-41 in 1985, improved upon the TRA by 
including the construct of perceived control over the performance of a behavior. 
Perceived control describes one’s perceived ability to perform a behavior, after taking 
into account environmental factors that may make it easy or difficult to perform that 
behavior.39 The TRA and TPB have been used for decades to explain health behaviors, 
including smoking, drinking, exercise, and the performance of health professionals.37,42 
Just as the TPB developed as a more explanatory extension of the TRA, the IBM is 
viewed as a more comprehensive extension of the TPB with the addition of constructs 
such as knowledge, salience, environmental constraints, and habits that increase our 
understanding of health behaviors.37 
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Figure 1: Theory of Reasoned Action (TRA) and Theory of Planned Behavior (TPB).37 
The unshaded boxes model the TRA while the unshaded boxes together with 
the shaded boxes model the TPB. 
 
 
 
1.3.2. The Integrated Behavior Model 
 
The IBM, illustrated in Figure 2, is a validated model that, like the TRA and TPB, 
postulates intent as the best predictor of behavior.37 Like previous models, the IBM 
includes three constructs that directly influence behavioral intent, attitude, normative 
beliefs, and control beliefs.37 In the IBM, attitude is subdivided into experiential attitude 
and instrumental attitude.37 Experiential attitude is one’s emotional response to the idea 
of performing a behavior while instrumental attitude is determined by beliefs about the 
outcomes of a behavior.37 Perceived norm is subdivided into injunctive norm and 
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descriptive norm.37 Injunctive norm involves beliefs about what others think one should 
do while descriptive norm involves perceptions about what others in one’s social or 
personal networks are doing.37 Personal agency has two components including self-
efficacy and perceived control.37 Self-Efficacy involves the confidence needed to perform 
a behavior in the face of challenges and perceived control as previously explained, is 
ones perceived amount of control over behavioral performance.37 The IBM introduces 
four additional constructs that directly affect behavior; knowledge, salience, 
environmental constraints, and habits.37 These four constructs that impact behavior 
directly, reflect findings that an observed behavior is more likely to be performed if one 
has the knowledge and skills necessary to execute the behavior, the behavior is deemed 
important, there are no environmental influences preventing the behavior, and the 
behavior has been performed previously.37 
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Figure 2: Integrated Behavior Model (IBM).37 
 
 
1.4. Current Study 
 
1.4.1. Purpose 
 
 
 HPV’s etiologic role in oral and oropharyngeal cancers demands that dentists and 
dental specialists be proactive, armed with knowledge, and effectively communicate with 
patients and their parents about the pathogenicity of the virus and availability of 
prophylactic vaccines.31 The prevalence of HPV vaccination in the U.S. population is far 
below the prevalence of routine childhood vaccinations.26 Because the majority of 
orthodontic patients are the primary target age for HPV vaccination and are seen by the 
orthodontist on a frequent, long-term basis during orthodontic treatment, this study 
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examined the determinants of orthodontists’ willingness to provide an HPV educational 
intervention to adolescent patients, and orthodontists’ agreement that HPV is within the 
scope of orthodontic practice. 	
 
 
1.4.2. Specific Aims 
Specific Aim 1: To describe the prevalence of Florida Orthodontists’ willingness to 
provide patients with an HPV educational intervention and/or administer 
the HPV vaccination. 
 
Specific Aim 2: To examine the association between Florida Orthodontists’ self-rated 
knowledge of HPV and the HPV vaccine with their willingness to provide 
patients with an HPV educational intervention. 
 
Hypothesis 1: Orthodontists’ willingness to provide patients with an HPV 
educational intervention will increase with greater self-rated 
knowledge of HPV and the HPV vaccine. 
 
Specific Aim 3: To examine the association between Florida Orthodontists’ agreement 
that HPV is within the scope of orthodontic practice and their willingness 
to provide patients with an HPV educational intervention.  
 
 Hypothesis 2: Orthodontists’ willingness to provide patients with an HPV   
  educational intervention will increase with agreement that HPV is  
  within the scope of orthodontic practice.  
 
Specific Aim 4: To examine the association between Florida Orthodontists’ 
encouragement during their professional education to either discuss HPV 
with their patients or recommend the HPV vaccine, and agreement that 
HPV is within the scope of orthodontic practice.  
 
 Hypothesis 3: Orthodontists’ agreement that HPV is within the scope of   
  orthodontic practice will increase with encouragement during their  
  professional education to either discuss HPV with their patients or  
  recommend the HPV vaccine. 
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Chapter 2: Materials and Methods 
2.1. Study 
 This cross-sectional study used data obtained from a survey administered to a 
representative sample of Florida Orthodontists. The survey instrument, informed by the 
IBM, was used to assess these orthodontists’ personal and practice demographic 
characteristics, knowledge regarding HPV and the HPV vaccine, orthodontists’ 
willingness to provide an HPV educational intervention to adolescent patients, and 
agreement that HPV is within the scope of orthodontic practice. We examined the 
determinants of orthodontists’ willingness to provide an HPV educational intervention 
and agreement that HPV is within the scope of orthodontic practice.  
 
2.2. Participants 
  The sampling frame was derived from an exhaustive search of the AAO 
membership directory for the state of Florida and the Yellow Page listings for each 
county in Florida. The combined list was cross-checked for duplicate entries resulting in 
a comprehensive listing of all Florida Orthodontists, both non-members and members of 
the AAO. The sample of prospective participants for this study was a representative 
sample of 474 orthodontists selected from the sampling frame. The inclusion criteria for 
study participants were as follows: English speaking orthodontists, who graduated from a 
CODA accredited postgraduate orthodontic program, and who were actively practicing in 
the state of Florida at the time of this study in February 2017. Individuals, who did not 
meet the inclusion criteria, as well as, orthodontists that served as full-time faculty at the 
Nova Southeastern University, College of Dental Medicine, Department of Orthodontics 
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at the time of this study, were excluded. The resulting sample included 15 (3%) 
participants without and 459 (97%) with membership in the AAO (Figure 3). Each 
participant was assigned a unique six-character (three-letter and three-digit) identifier for 
anonymity and tracking purposes. 
 
Figure 3: American Association of Orthodontists membership  
 status within the study sample  
 
2.3. Focus Group Procedures 
Ten participants were selected and agreed to partake in focus group interviews 
during development of the survey instrument. Five of the ten participants were randomly 
selected from the sample of 474 orthodontists currently practicing in the state of Florida 
using a web-based random number generator. The remaining five were selected by 
convenience from among the Florida Orthodontists that currently serve as adjunct faculty 
members in the Department of Orthodontics within the College of Dental Medicine at 
Nova Southeastern University. Adjunct faculty members were not included in the original 
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sample of 474 orthodontists currently practicing in the state of Florida. Focus group 
participants were excluded from participating in the survey.  
 
According to Fishbein,43 the beliefs underlying a particular health behavior may 
be different for different populations. Therefore, an elicitation phase was a requirement 
for survey design to ensure that the survey was valid for the intended target population.43 
The elicitation phase for our study consisted of open-ended telephone interviews that 
identified beliefs of our sample population to permit appropriate measurement of 
constructs of the IBM within our survey instrument.37 Specifically, interviews assessed 
attitudes towards performing and the outcome of performing an HPV educational 
intervention, the impact other individuals or groups may have on performing an HPV 
educational intervention, and certain facilitators or barriers to delivery of an HPV 
educational intervention.37 This information helped to specify questionnaire content.37 
Focus group interviews were also used to confirm face validity by asking participants 
questions such as, “Do you understand what this item is asking you? Why or Why not?” 
and “Do you feel confident that the responses you gave accurately represent your views, 
beliefs, or opinions? Why or why not?”  
 
2.3. Survey Instrument 
  The 29 item survey instrument used in this study was informed by the IBM.37 
Survey instrument design, with respect to content validity, item content, construction, and 
response scales, was based upon recommendations from experts and the literature 
regarding the use of the IBM.37,44 Completion of the self-administered survey instrument 
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required ten to fifteen minutes of the participant’s time and was completed in one sitting. 
Study participant responses were submitted by either return of the mailed hardcopy 
survey instrument or by electronic submission on the REDCap website, an online 
application for construction, administration, and management of digital survey 
instruments. Hardcopy responses were entered manually into a Microsoft Excel 
spreadsheet individually, by both the principal investigator and a research assistant, and 
the data was later compared for accuracy. Electronic submissions were automatically 
recorded in REDCap and exported as an Excel spreadsheet. Finally, hardcopy and 
electronic response spreadsheets were merged and used for data analysis. Participant 
email addresses and contact information were disassociated from survey response data 
and stored in a file on a separate password protected university server.  
 
2.5. Solicitation and Recruitment 
Dillman’s Total Design Method (TDM) informed the survey administration for 
the current study.45 The TDM includes a prescribed series of contact communications 
with prospective participants in order to maximize survey response rates.45 The initial 
contact prescribed by the TDM, is a mailed cover letter outlining the purpose of the study 
along with the survey instrument.45 One-week later, a reminder postcard is sent, followed 
by an additional questionnaire booklet three weeks and seven weeks after the initial 
mailing to non-respondents.45 Survey administration in our study followed a modification 
of the TDM, both in contact modalities and communications timing.  
 
Communication with prospective participants utilized a series of structured 
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mailings and emails administered by REDCap. Postal and email addresses were acquired 
from the AAO membership directory and the Yellow Page listings. An initial hardcopy 
mailing contained an introductory letter, informed consent statements, and hardcopy of 
the survey instrument with a pre-addressed, stamped envelope to return the survey. 
Subsequent REDCap emails included an invitation to participate with an explanation of 
the study and its purpose, as well as an embedded hyperlink to the electronic informed 
consent and survey instrument that was housed on the REDCap website. A 4”x 6” 
reminder postcard included an invitation to participate with an explanation of the study 
and its purpose, as well as a REDCap web address to permit informed consent and 
completion and submission of the survey instrument. Following acceptance of the 
informed consent, respondents were provided the self-administered survey instrument. 
Individuals wishing to decline participation in the study could withdraw at study 
initiation or opt-out from the study at any time without consequences. Incomplete survey 
instruments were included in the study. All communications with prospective participants 
included the primary investigator’s contact information so that participants could ask 
questions if necessary at any time during the study.  
 
Contact communications were staged to allow ample participant response time but 
amended from those communications prescribed by the TDM. At each step in the 
communication process, prospective participants were thanked for their time and effort to 
participate, and contribution to furthering an important research effort. In addition, 
participant identifiers were used at each stage of communication only to ensure that those 
who had previously submitted survey responses were excluded from all further 
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communications. Two weeks following the initial mailing, the principal investigator sent 
a solicitation email, followed by two additional solicitation emails, each at two-week 
intervals, to non-respondents via the REDCap website. One week following the final 
email, a postcard was sent to non-respondents to encourage participation. A final 
telephone call to non-respondents was placed two weeks following the postcard mailing 
to request submission of either the hardcopy or emailed survey.  
 
To encourage participation and to acknowledge and thank individuals for their 
time and effort in advancing our research endeavors, opportunities to enter a drawing 
were provided as incentives. Incentives were offered to those who participated in the 
focus group elicitation phase and to participants who completed the survey. The 
incentives offered were entries into a drawing for a 42mm Apple iWatch at the 
completion of the study. The number of drawing entries granted depended upon the 
solicitation stage when each participant submitted a completed survey. Each participant’s 
random 6-character alphanumeric identifier was used to track survey submission in 
relation to the stage of solicitation in order to appropriately assign drawing entries. Each 
drawing entry for each participant was recorded by saving the participant’s alphanumeric 
identifier to a single row, in the first column of a Microsoft Excel spreadsheet. Multiple 
drawing entries were recorded by saving the participants’ alphanumeric identifier on 
multiple rows in the same column of the spreadsheet.  
 
The method of awarding drawing entries for each solicitation stage was as 
follows. One entry was provided for those who participated in the focus group elicitation 
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interviews. Participants received a single entry into the incentive drawing after 
completing the hardcopy survey or first emailed survey. Two drawing entries were 
awarded for completion of the second and third emailed surveys. Following the 
dissemination of the third solicitation email, fewer responses were received from study 
participants than anticipated. The principle investigator and research assistants 
subsequently placed telephone calls to non-respondents in order to confirm email 
addresses and encourage participation. A fourth and final solicitation email was then sent 
one week following the third email. Three drawing entries were awarded for completed 
surveys received following the final solicitation email. One week following this final 
email, a postcard was sent to non-respondents to again encourage participation. Five 
drawing entries were awarded for completed surveys received following the reminder 
postcard. The principal investigator and research assistants placed a final telephone call 
to non-respondents, two weeks following the postcard mailing, to request submission of 
either the hardcopy or emailed survey. Ten drawing entries were awarded for completed 
surveys received after the final telephone solicitation. Following the study, one identifier 
was randomly selected from this column using a web-based random number generator, 
the study participant was contacted and the Apple iWatch incentive was awarded. The 
institutional review board of Nova Southeastern University approved our study design, 
methods, and protocols. 
 
2.6. Dependent Variables  
For Specific Aim 1, prevalence was measured by a survey item response to 
whether orthodontists would be willing to provide an HPV educational intervention 
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and/or administer the HPV vaccine to their patients, based on a 4-point Likert scale 
dichotomized to “willing” vs. “un-willing”. The dependent variable for Specific Aims 2 
and 3 was also the dichotomized “willingness” Likert response to the survey item that 
assessed whether orthodontists would be willing to provide patients with an HPV 
educational intervention. For Specific Aim 4, the dependent variable was measured by a 
survey item response to whether orthodontists agreed HPV was out of the scope of 
orthodontic practice, based on a 4-point Likert scale dichotomized to “agree” or 
“disagree”. For ease of interpretation, this variable was then recoded to assess agreement 
that HPV was within the scope of orthodontic practice. 
 
2.7. Independent variables 
 For Specific Aim 2, the primary independent variables of interest were measured 
by survey item responses to orthodontists’ self-rated knowledge of HPV and the HPV 
vaccine based upon a 4-point Likert scale dichotomized to “none or limited” vs. 
“moderate”, “good”, or “excellent”. The primary independent variable of interest for 
Specific Aim 3, was a response to whether orthodontists agree HPV was out of the scope 
of orthodontic practice, measured by a Likert scale, dichotomized to agree or disagree. 
For ease of interpretation, this variable was then recoded to assess agreement that HPV 
was within the scope of orthodontic practice. For Specific Aim 4, the primary 
independent variable of interest was measured by a survey item response to assess 
Florida Orthodontists’ encouragement during their professional education to either 
discuss HPV with their patients or recommend the HPV vaccine dichotomized to “yes” or 
“no”. 
	 24	
 
Additional independent variables included respondents’ sociodemographic 
characteristics (age, sex, race/ethnicity), characteristics of respondents’ orthodontic 
practices (years in practice, practice setting, number of patients treated daily, and the 
number of patients treated that are ≤17 years or ≥18 years of age), and responses to 
survey items informed by the domains of the IBM. The IBM domains used included 
Perceived Norm (Injunctive Norm), Knowledge, Personal Agency (Self-Efficacy and 
Perceived Control), Salience, and Environmental Constraints.  
 
2.8. Statistical Analysis 
The study included univariate, bivariate, principle component, and multivariable 
logistic regression analyses. The univariate analysis described the socio-demographic and 
background characteristics of our sample by reporting the means and standard deviations 
of the continuous variables and frequencies and proportions of categorical variables. The 
bivariate analyses evaluated the unadjusted associations between the two dependent 
variables and each of the independent variables. Principle component analysis was 
employed to identify if groups of seemingly correlated observed variables (survey items) 
could be transformed into linear combinations of optimally weighted observed variables 
creating artificial variables, known as principal components, that explain most of the 
variance of the observed variables. Factor scoring was used to weight the contribution 
each observed variable made to the constructs and then the resulting principal 
components were assessed to determine if they could be identified as constructs of the 
IBM. The multivariate logistic regression analyses examined associations between 
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dependent variables and the independent variables of interest and covariates (including 
principal components) as outlined in the specific aims. Multivariable model building 
began by initially including independent variables demonstrating an unadjusted bivariate 
association with the dependent variable with a p-value ≤ 0.25. Each of the models were 
further reduced in a stepwise fashion, resulting in the most parsimonious model with best 
model fit and explanation of variance in the dependent variable, following the method 
outlined by Hosmer and Lemeshow.46 Sociodemographic and practice characteristic 
variables were forced into the regression models to control for potential confounders, 
independent of p-values. Robust standard errors were utilized in the process in order to 
accommodate problems of normality, heteroscedasity, and observations that exhibited 
large residuals, leverage, or influence. 
 
Multivariable logistic regression (MLR) analysis was used to examine all 
dichotomous outcomes. Pass 14 software (NCSS, LLC, Kaysville,	Utah) that employs 
Hsieh’s power estimation method47 was used for our power analysis. The power 
calculation assumed a sample size of 450 participants and an unadjusted baseline 
proportion of orthodontists’ willingness to provide an HPV educational intervention of at 
least P0 = 0.50, demonstrated by a similar study.42 We estimated the smallest effect size 
(i.e., odds ratio), detectable as a function of power for one dichotomous dependent 
variable and as many as 10 covariates (Figure 4). The MLR analyses are estimated to 
detect OR’s from 1.71 to 1.79, comparable to Cohen’s “d” small effect size48 with a 
power of 80%, and larger effect size detection is estimated with power greater than 80%. 
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Figure 4: Power calculation for multiple logistic regression  
analysis. Odds ratio (OR) = 1.71 -1.79 detectable with  
80% power (for R2 = 0.01 – 0.16, respectively). 
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Chapter 3: Results 
 
 
3.1. Participation Summary 
 
 Among the 469 Florida Orthodontists recruited to complete a survey instrument, 
119 responded with completed surveys, resulting in a 25.4% response rate. The majority 
of participants completed the hardcopy survey (64%) while the remainder completed the 
web-based version (36%). The incentive offered upon response submission was an entry 
or entries into a drawing for a 42mm Apple iWatch at the conclusion of the study. As 
described above, the number of entries was dependent upon the stage of solicitation at 
which the completed survey was received. Accordingly, 72% of respondents received one 
entry, 19% of respondents received two entries, 4% of respondents received three entries, 
1% received five entries, and 3% of respondents were awarded ten entries into the lottery 
in appreciation of their participation. 
 
 
3.2. Descriptive Statistics 
 
 Descriptive statistics provide a summary of the participants in our study and are 
presented in Table 1. The majority of these participants were male (63%) with an average 
age of 48.6 years. Whites were the most represented racial group (86%) followed by 
Other (7%), Asian (4%), and Black (3%) and regarding ethnicity, 16% were 
Hispanic/Latino. 
 
  The participants in our study had practiced an average of 18-years, and more than 
half (54%) graduated from their residencies after the year 2000. Nearly three-fourths of 
respondents were in solo practices (74%), almost all reported working in a private 
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practice setting (96%) and in urban areas (92%). More than a third of participants (37%) 
reported daily patient volume between 51-75, followed by 30% who reported between 
26-50 patients per day, while 17% reported practices, with more that 75 patients per day. 
Additionally, participants reported that the majority of patients in their practices (72%) 
were 17 years of age or younger. 
 
 Less than 11% of respondents reported having none/limited self-rated knowledge 
of HPV and its modes of transmission. Evidence of our participants’ baseline knowledge 
was observed by the high percent of participants who recognized that HPV causes cancer 
in females (95%) and males (80%), is sexually transmitted (93%), and is preventable 
(97%). While 68% of respondents reported learning about HPV during their education, 
only 11% were encouraged to either discuss HPV with, or recommend the HPV vaccine 
to their patients during professional training. Additionally, more participants reported a 
moderate, good or excellent level of self-rated knowledge of routine childhood 
vaccinations (88%) compared to that of the HPV vaccines (73%).  
 
 Most participants reported that they needed additional knowledge about HPV 
prevention (86%) and information about vaccine administration (79%), as well as 
information on how to effectively discuss HPV with their patients (86%). Almost 90% of 
the participants reported that patients were most often referred to their primary care 
providers for follow-up of medical conditions, and two-thirds of participants stated that 
they knew where to refer their patients for HPV vaccination, however only a little more 
than half (57%) knew where they could refer patients for HPV information.  
	 29	
  
While 93% of participants agreed they were not only responsible for their 
patients’ oral health, but also, patients’ overall health, less than half the respondents 
(46%) agreed that HPV was within the scope of orthodontic practice. Moreover, although 
64% of participants believed communication with patients and their parents about HPV is 
important, none reported providing patients informational pamphlets or educational 
videos regarding HPV and only 3% reported ever discussing HPV with patients and their 
parents. Regarding future behaviors, 55% and 66% of respondents, respectively, were 
unwilling to either discuss HPV with their patients or present an HPV informational 
video. Yet, 68% of the respondents reported a willingness to offer HPV informational 
pamphlets within the next year. Moreover, only 32% of participants considered it their 
responsibility to personally deliver HPV educational intervention, and more than half 
agreed delivering HPV educational interventions could be delegated to a chairside 
assistant, or treatment coordinator/office manager, 53% and 52%, respectively. The 
majority of respondents (64%) reported they would offer HPV educational intervention 
regardless of third-party reimbursement and few participants (19%) expected 
reimbursement in return for such a service; however, nearly three-fourths (74%) were 
willing to devote only two minutes or less to providing an HPV educational intervention.  
 
More than three-quarters of respondents (82%) agreed that they would feel that 
they were acting in the patients’ best interest by providing HPV educational 
interventions, however, only 40% reported that they would feel comfortable doing so. 
Three-fourths of participants agreed that patients and their parents would be 
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uncomfortable if they offered HPV educational intervention and more than half (52%) 
were afraid that patients would be offended if they did. Similarly, only 31% respondents 
agreed patients and their parents were amenable to HPV educational interventions in the 
orthodontic setting. In addition, only 30% of participants agreed that their colleagues’ 
perception of them as orthodontists would improve and 36% agreed that their patients’ 
perception of them as orthodontists would improve if they offered HPV educational 
intervention.  
 	 Notably, 81% of participants reported that it was important to vaccinate children 
between the ages of 11 and 12 years for HPV, but 74% were not willing to deliver the 
vaccine, even if administration of vaccines were considered to be within the scope of 
dental practice. Similar to responses regarding discussing HPV with patients and parents, 
72% of respondents felt if they offered the HPV vaccine they would be acting in their 
patients’ best interest, only 26% agreed their colleagues’ perception of them as 
orthodontists would improve and 27% agreed that their patients’ perception of them as 
orthodontists would improve, if they did so. Finally, 62% of participants agreed that they 
would be concerned about negative reactions from patients if they offered the HPV 
vaccine. 
 
 
3.3. Principle Component Analysis – Factor Loading  
 
 Table 2 presents the results of the principle component analysis (PCA). Factor 
loading occurs when seemingly correlated observed variables (survey items) are 
transformed into linear combinations of optimally weighted observed variables, creating 
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principal components that independently account for the maximum amount of variance in 
the data set not accounted for by previous components and are uncorrelated with other 
components. According to Clark and Watson,49 meaningful principal components must 
have three or more variables loading. In our study, seven components were identified and 
six retained from the PCA. The six components described conceptual constructs of the 
IBM that included, Perceived Norm (Injunctive Norm), Knowledge, Personal Agency 
(Self-Efficacy and Perceived Control), Salience, and Environmental Constraints. One of 
the seven identified components was uninterpretable and consequently not used. The 
IBM constructs of Attitude and Habit were not identified as principal components within 
our response data.  
  
 The variables that loaded on the component representing Injunctive Norm 
examined respondents’ agreement that their colleagues’ and patients’ perception of them 
would improve if they offered HPV educational intervention and the HPV vaccine, 
agreement they would make patients and their parents uncomfortable if they discussed 
HPV, and their willingness to discuss HPV with patients and parents. Self-rated 
knowledge of HPV and the HPV vaccine, routine childhood vaccines and modes of 
disease transmission, as well as agreement that additional knowledge regarding HPV 
prevention is required, were variables which reflected the conceptual construct of 
Knowledge. The Self-Efficacy construct was composed of variables that assessed whether 
respondents knew where to refer patients for HPV information and vaccination. Variables 
that loaded under Salience examined whether orthodontists were encouraged to discuss 
HPV and recommend the vaccine to patients during their education, agreement they 
	 32	
would be afraid of offending patients if they offered HPV educational intervention, 
agreement they would be concerned about negative reactions from patients if they offered 
the HPV vaccine, where they most often refer for follow-up of medical conditions, and 
agreement that HPV educational intervention can be delegated to a treatment coordinator 
or office manager. Importance of HPV communication, agreement that additional HPV 
discussion skills and vaccination information are required, willingness to give an HPV 
informational pamphlet, and agreement that orthodontists are responsible for overall 
patient health were variables that loaded on the construct identified as Perceived Control. 
Finally, variables that loaded on the IBM construct identified as Environmental 
Constraints questioned whether participants learned about HPV during their professional 
training, agreement that HPV is a preventable disease, reimbursement expectation for 
HPV educational intervention, and agreement to provide educational intervention without 
reimbursement.  
 
 
3.4. Multivariable Logistic Regression 
 Multivariable logistic regression was used to examine the determinants of 
orthodontists’ willingness to provide an HPV educational intervention (Table 3) and 
orthodontists’ agreement that HPV is within the scope of orthodontic practice (Table 4) 
by computing adjusted odds ratios (AOR). Model building began with those variables 
forced into the model (sociodemographic and practice characteristic variables), 
independent variables outlined in Specific Aims 2-4, the six constructs of the IBM 
identified by the PCA, and all remaining covariates with a p-value ≤ 0.25. Model 
building then proceeded with stepwise deletion of non-significant variables, resulting in 
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the most parsimonious and explanatory model following method of Hosmer and 
Lemeshow.46  
 
 
3.4.1. Willingness to provide patients with an HPV educational intervention. 
 As presented in Specific Aims 2 and 3, we examined associations between Florida 
Orthodontists’ self-rated knowledge and agreement that HPV is within the scope of 
orthodontic practice, and their willingness to provide patients with an HPV educational 
intervention. Neither self-rated knowledge nor agreement that HPV is within the scope of 
orthodontic practice, were significant determinants of orthodontists’ willingness to 
provide an HPV educational intervention. However, for each year that participants’ aged, 
the adjusted odds of willingness increased 12% (AOR = 1.12, 95% CI 1.02, 1.23). 
Additionally, for those participants who agreed that HPV causes cancer in females, they 
were four times more willing to provide an HPV educational intervention than those who 
disagreed that HPV causes cancer in females (AOR = 4.07, 95% CI 1.51, 10.94). Of the 
six components identified from the PCA and included in the regression model, two were 
statistically significant determinants of orthodontists’ willingness to provide an HPV 
educational intervention to patients, namely, Perceived Control and Salience. After 
controlling for Gender, Age, Race, Hispanic/Latino ethnicity, and other covariates, for 
each 1-unit increase in Perceived Control, the odds of orthodontists’ willingness were 
two times greater than their unwillingness to provide an HPV educational intervention 
(AOR = 2.03, 95% CI 1.06, 3.90). In addition, orthodontists’ adjusted odds of willing vs. 
unwilling to provide an HPV educational intervention was three times greater for every 
1-unit increase in Salience (AOR = 3.09, 95% CI 1.35, 7.09), after controlling for 
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sociodemographic variables and other covariates. However, Self-Efficacy (AOR = 5.40, 
95% CI 0.94, 31.2), agreement that delivering educational intervention can be delegated 
to a chairside assistant (AOR = 1.42, 95% CI 0.86, 2.34), and the amount of office time 
respondents were willing to spend to provide an HPV educational intervention to their 
patients (AOR = 9.72, 95% CI 0.72, 130.94), were not statistically significant 
determinants of orthodontists’ willingness to provide an educational intervention.  
 
3.4.2. Agreement that HPV is within the scope of orthodontic practice.  
 
 Specific Aim 4 examined the association between Florida Orthodontists’ 
encouragement to either discuss HPV with their patients and/or recommend the HPV 
vaccine during their professional education and their agreement that HPV is within the 
scope of orthodontic practice. Model building followed the methods used in Specific 
Aims 2 and 3. After controlling for sociodemographic and practice characteristics, neither 
of the primary independent variables of interest, namely, encouragement to discuss HPV 
with their patients and/or recommend the HPV vaccine during their professional 
education, were statistically significant determinants of Florida Orthodontists’ agreement 
that HPV is within the scope of orthodontic practice. The only significant determinant of 
participant orthodontists’ agreement that HPV is within the scope of orthodontic practice 
was the amount of office time that respondents were willing to allocate to HPV 
educational interventions within their practices. The more office time respondents could 
provide to deliver HPV information to patients, the adjusted odds of agreement were 
greater. For respondents willing to spend less than 1 minute providing HPV information, 
the adjusted odds of agreement was over seven times greater than their disagreement 
(AOR = 7.55, 95% CI 1.09, 52.33), for 1-2 minutes over twenty-one times greater (AOR 
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= 21.20, 95% CI 3.44, 130.52), and for 3-4 minutes over forty-one times greater (AOR = 
41.05, 95% CI 6.04, 279.12). Neither Perceived Control (AOR = 1.53, 95% CI 0.82, 
2.85) nor Salience (AOR = 0.72, 95% CI 0.46, 1.13) were statistically significant 
determinants of orthodontists’ agreement that HPV is within the scope of orthodontic 
practice. 
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Chapter 4: Discussion 
HPV is the most common sexually transmitted virus and while most infections 
resolve through normal immunogenic processes, HPV can cause a number of health 
sequelae that range from benign warts to invasive cancers.1,2 HPV has been identified as 
an etiologic agent for oropharyngeal cancers, making HPV particularly relevant to 
dentists and dental specialists.5,6,9,31 While few long-term studies have considered the 
efficacy of three FDA-approved vaccines in the prevention of oropharyngeal cancers, 
current evidence is promising. One study examined the efficacy of Cervarix in 5,840 
Costa Rican women as part of a double-blind controlled trial.50 Four years after 
vaccination, there were fifteen prevalent oral HPV16/18 infections in the control group 
and only one in the vaccine group, with an estimated vaccine efficacy of 93.3%.50 
Despite such encouraging data, dentists and dental specialists remain surprisingly 
underutilized in addressing the low HPV vaccination rates in this country.  
 
In 2014, 83% of children aged 2-17 years, visited a dentist (including specialists 
such as orthodontists) in the previous year.34 Because patients visit orthodontists 
frequently and for prolonged periods, orthodontists have multiple, continuing 
opportunities to offer patients and their parents important educational information 
regarding HPV and the need to vaccinate, that has been previously overlooked. 
Orthodontic specialists are particularly well positioned for this role given the majority of 
their patients are within the target ages for the vaccine.26 According to the AAO, nearly 
three-quarters of patients treated by orthodontists in 2014 were 17 years of age or 
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younger.35,36 This is consistent with our findings that a majority of patients (72%) in the 
practices of our study participants were 17 years of age or younger.  
  
 The role of dentists and dental specialists in the prevention of HPV-related 
malignancies remains a subject of limited research.32,33 Few studies have examined 
barriers or facilitators associated with provider-driven HPV educational intervention in 
the dental setting and, to our knowledge, none in the orthodontic setting. One fact is 
clear, despite the opportunities of frequent, long-term patient contact provided by 
orthodontists to deliver an HPV educational intervention, our study revealed the 
orthodontic venue is underutilized for this important and timely interaction between 
orthodontists, patients and their parents. Daley et al.,32 found that more than 52% of 
Florida dentists reported no intention to discuss the HPV vaccine with their female 
patients. Daley et al.,32 concluded that lack of intent was due to discomfort discussing 
sexual health related topics, absence of guidelines or oversight from dental professional 
organizations, and an interaction viewed as outside the scope of dental practice. Such 
findings are consistent with our study that indicated the majority of participant 
orthodontists were uncomfortable discussing HPV with patients and their parents and if 
they did so, were afraid they would offend their patients. In spite of expressed concern of 
parents’ reactions by our participants, there is evidence that suggests that parents would 
not only be amenable to the receipt of HPV information in the orthodontic care setting, 
but also, willing to allow their children to receive the HPV vaccination, if only the 
orthodontist would recommend vaccination.33 Shapiro33 examined parents’ willingness to 
allow their child to receive the HPV vaccine and reported that the strongest predictor of 
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parents’ willingness to receive the HPV vaccine was if parents considered vaccination 
salient. Shapiro33 found that a critical factor contributing to parents’ perception of 
salience was receipt of a recommendation to vaccinate from an orthodontist. This 
suggests that orthodontists are important parental influencers with respect to overall 
health and furthermore, that a recommendation from an orthodontist regarding HPV 
immunization predicts a parent’s decision to vaccinate.33 Apparently, orthodontists’ 
influence over their patients’ health behaviors is greater than orthodontists realize. 
Shapiro’s33 findings suggest that orthodontists may have a critical impact on parents’ 
willingness to allow their children to receive the HPV vaccine. Perhaps, dissemination of 
Shapiro’s findings could positively influence orthodontists and orthodontic leadership of 
this important missed opportunity to positively impact patient health.  	 		 Our study is among the first to assess orthodontists’ attitudes and beliefs 
regarding HPV educational intervention in the orthodontic care setting. We examined 
participant orthodontists’ agreement that HPV is within the scope of orthodontic practice 
and their willingness to provide an HPV educational intervention to patients. 
Furthermore, our study sought to identify barriers or facilitators associated with offering 
an HPV educational intervention, and to understand what mode of intervention 
orthodontists’ would be willing to deliver. 
  
 We hypothesized that orthodontists’ agreement that HPV was within the scope of 
orthodontic practice would increase with encouragement during professional education to 
either discuss HPV with, or recommend the HPV vaccine to their patients. Neither 
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encouragement to discuss HPV nor recommend the HPV vaccine during professional 
education were significant determinants of orthodontists’ agreement that HPV was within 
the scope of orthodontic practice. In fact, 54% of our participants disagreed that HPV is 
within the scope of orthodontic practice, similar to Daley et al.,32 who found that Florida 
dentists responded that HPV was not within the scope of dental practice. However, the 
amount of office time respondents would be willing to provide to deliver HPV 
information to patients was a significant predictor of agreement that HPV was within the 
scope of orthodontic practice (AOR = 2.13, 95% CI 1.17, 3.86). Indeed, 70% of 
participant orthodontists in our study reported they could provide some amount of office 
time to deliver HPV information. It is not difficult to infer that the more time respondents 
were willing to dedicate to the delivery of HPV information, the more likely they were to 
agree that HPV was within the scope of orthodontic practice. Our participants 
overwhelmingly reported a need for additional knowledge regarding skills for effectively 
communicating about HPV and HPV prevention with patients and their parents. Perhaps 
this highlights an opportunity for the AAO to provide proactive guidance that could 
support orthodontists’ need for knowledge and promote an understanding that HPV is 
within their purview. 
 
 We also hypothesized that orthodontists’ willingness to provide patients with an 
HPV educational intervention would increase with greater self-rated knowledge of HPV 
and the HPV vaccine and with agreement that HPV is within the scope of orthodontic 
practice. Neither self-rated knowledge nor agreement that HPV is within the scope of 
orthodontic practice, were significant determinants of orthodontists’ willingness to 
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provide an HPV educational intervention. These findings also are consistent with those of 
Daley et al.,32 in that HPV-related knowledge was also not a predictor of dentists’ 
readiness to discuss HPV with their patients. However, agreement that HPV causes 
cancer in females was a significant predictor of willingness to provide an HPV 
educational intervention in our study, suggesting a rudimentary understanding of the 
virus does indeed play a role in willingness. To help understand this inconsistency, it is 
important to note that the majority of our sample (73%) completed their postgraduate 
orthodontic residency programs before 2010, the year the American Dental Association 
(ADA) acknowledged HPV as a risk factor for oropharyngeal cancers.51 Furthermore, it 
was only in 2006 that one of the largest U.S. pharmaceutical companies, Merck and 
Company, obtained approval for the first HPV vaccine.18 Therefore, it is possible that 
many of our participants are unfamiliar with the most current scientific evidence 
pertaining to virus sequelae and the strain-specific vaccines that prevent HPV infections. 
Perhaps this unfamiliarity minimized the role of self-rated knowledge in participants’ 
willingness to provide an HPV educational intervention. In fact, two studies have 
assessed dentists’ knowledge regarding HPV and its relationship to oropharyngeal 
cancers.52,53 Daley et al.,52 reported deficits in dental professionals’ knowledge of the 
pathogenesis of HPV and the impact of HPV on overall health. Vázquez-Otero et al.,53 
found confusion among dentists regarding differences between low and high risk strains 
of the HPV virus and the implications in the development of certain cancers.53 Data 
suggests dentists may need additional knowledge to provide patients with the most up-to-
date information regarding HPV and the HPV vaccine.52,53 Consistent with these 
findings, participant orthodontists in our study reported a need for additional knowledge 
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regarding HPV prevention (86%). This not only highlights the importance of professional 
school education in preparing clinicians to effectively discuss HPV and the HPV vaccine 
with patients and their parents, but also of continuing education and a professional’s role 
and responsibility to be a life-long learner and seeker of knowledge. 
 
 We found that Perceived Control and Salience, were significant determinants of 
orthodontists’ willingness to provide an HPV educational intervention. The IBM 
construct, Perceived Control, was composed of survey items assessing agreement that in 
order for our participants to contribute to a public health effort aimed at increasing HPV 
vaccination rates among their adolescent patients, additional information about discussing 
HPV effectively (79%) and about vaccine administration (86%) were needed. Clearly, 
our respondents perceived that they lacked sufficient skills to effectively communicate 
with their patients about HPV and the HPV vaccine. It may be that these insecurities 
result from most respondents (89%) report of a lack of encouragement to either discuss 
HPV or the HPV vaccine during their education. Furthermore, such insecurities may be 
the reason that more than half of our participants (55%) were unwilling to have a direct 
conversation with patients and their parents regarding HPV. Encouragingly, 68% of 
respondents reported a willingness to provide patients with an HPV informational 
pamphlet within the next 12-months. These findings suggest an obvious opportunity for 
the AAO to support orthodontists in impacting HPV vaccination rates among their 
patients by development and provision of educational pamphlets. It may be that such 
pamphlets are a reasonable solution to the dichotomy between perceived insufficient 
skills, reluctance to have direct conversations, and the importance of HPV. 
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 Salience was one of the most impactful determinants of participants’ willingness 
to provide an HPV educational intervention. Variables that loaded on the construct of 
Salience included encouragement to discuss HPV or recommend the vaccine during 
professional education. Our findings suggest that few participants were encouraged to 
discuss HPV or recommend the vaccine during professional education. Promisingly, 
Poelman et al.,54 found that current pre-doctoral and post-doctoral students placed value 
in HPV vaccine discussions with patients and desired more education in oral cancer 
detection. Such findings are corroborated by a recent editorial entitled “Could Your Next 
Doctor Be Your Dentist”, by Nisarg Patel,55 a senior Harvard Dental School student. 
Patel55 suggested a broader scope of dental practice that includes preventive primary 
healthcare to address the shortage of affordable healthcare in the United States. To 
accomplish this, Patel55 explained that more dental schools need to adopt a 
comprehensive medical education model. Encouragement to discuss HPV and 
recommend the HPV vaccine during dental education may provide a first step in 
beginning to change orthodontist’s attitudes about the appropriateness of discussing HPV 
and habituate orthodontists to such discussions with patients.  
 
 The majority of participant orthodontists reported the importance of 
communication with patients and parents about HPV despite their unwillingness to do so. 
Perhaps the time is ripe for orthodontists to exercise their professional responsibilities 
and act on their beliefs related to overall patient health and the importance of childhood 
vaccinations and communication about HPV. Indeed, orthodontists have a unique 
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opportunity with repeated long-term contact with adolescents, the population most at risk 
to HPV. Adolescents are also the target age group for the HPV vaccine. As such, 
orthodontists are in the driver’s seat of what may be considered the “ground zero” venue 
for delivering effective HPV prevention efforts. Mobilizing orthodontists in such efforts 
requires a collaborative approach, emphasizing their unique position in healthcare. It 
seems reasonable to suggest that the AAO may play a pivotal role given that both the 
ADA and the ADA Council on Scientific Affairs encourage dentists to educate 
themselves and their patients about the relationship between HPV and oropharyngeal 
cancer.56 After all, Daley et al.,32 found that dentists seek approval and guidance from 
their professional organizations. Orthodontists may turn to the AAO for support and 
guidelines in fulfilling their reported responsibility to overall patient health, and in doing 
so, aid in the development of effective means to implement educational interventions in 
the orthodontic practice setting.  
 
 Because Salience was a statistically significant predictor of orthodontists’ 
willingness to provide an HPV educational intervention in our study, a paradigm shift is 
necessary, whereby the importance of orthodontists’ role in the prevention of HPV is 
communicated by the AAO to its member orthodontists. As health professionals, 
orthodontists can no longer sit idly by and accept the rising incidence of HPV-related 
cancers as anything other than preventable. Our study reveals specific opportunities for 
orthodontists’ to fulfill their self-reported obligation to overall patient health, by 
contributing to a necessary public health effort to increase the low HPV vaccination rates 
in this country. It is time for orthodontists, with the support of their professional 
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organizations and the institutions that educate them, to mobilize and collectively halt the 
spread of HPV infections.  
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Chapter 5: Conclusions  
 Orthodontists have an ethical responsibility to address low HPV vaccination rates, 
a critical public health issue. However, a clear disconnect exists between how 
respondents view their roles and responsibilities as healthcare providers, and their 
actions. This disparity highlights the need for targeted interventions to mobilize 
orthodontists to fulfill their self-reported obligation to overall patient health. Our findings 
suggest an opportunity to impact orthodontists’ willingness to provide an HPV 
educational intervention by encouraging and preparing clinicians to discuss HPV and the 
HPV vaccine effectively in professional school and continuing education, the availability 
and dissemination of informational pamphlets, and support and guidance from the 
American Association of Orthodontists (AAO). Such support and guidance from the 
AAO is necessary to promote orthodontists’ understanding that HPV is within the scope 
of orthodontic practice. This study provides a foundation for future public health efforts 
aimed at addressing low HPV vaccination rates by outlining approaches to mobilize a 
potentially potent, but previously overlooked, venue for HPV prevention. 
 
 
5.1. Strengths and Limitations 
A strength of our study is that it is among the first to examine orthodontists’ 
willingness to provide an HPV educational intervention by representative sampling of 
Florida Orthodontists. Moreover, our study was informed by the Integrated Behavior 
Model (IBM); a valid measurement of behavioral intent appropriate to our specific aims. 
Our study was further strengthened by use of focus group elicitations that identified 
beliefs of our sample population in order to permit accurate measurement of IBM 
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constructs within our survey instrument.37 The low survey response rate (25.4%) was a 
limitation of this study despite fidelity to accepted methods of survey administration. 
Given that only a quarter of our sample responded, the threat to validity is that there may 
be systematic differences between respondents and non-respondents, and as such, our 
results may not be representative of the population studied. In fact, the low response rate 
may be an important finding in itself, as an indicator of the magnitude of effort required 
to communicate the importance of HPV vaccination to orthodontists. Nonetheless, the 
findings of this study will help inform future public health interventions using a potent, 
yet underutilized, healthcare venue targeted towards increasing orthodontic patients’ and 
their parents’ awareness and knowledge of HPV and the HPV vaccines with the intent of 
increasing HPV vaccination rates among adolescents.  
 
5.2. Future Studies 
 
 Because so little has been published regarding the role of the dental profession, 
and orthodontists in particular, in positively contributing to an increase in HPV 
vaccination rates among adolescents, there are many topic areas for future research. For 
example, future research may examine the impact of HPV educational intervention (i.e., 
delivering informational pamphlets) on HPV vaccination rates in the orthodontic care 
setting. Furthermore, there is need to examine the association between official guidelines 
released by the AAO regarding HPV, and prevalence of orthodontists providing HPV 
information to their patients, whether the current mode of information dissemination is 
effective, or if there may be more effective means to disseminate such information. 
Future research may also evaluate the impact of a pilot pre-doctoral dental curriculum 
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that emphasizes the impact of oral health on overall systemic health, and focuses on HPV 
by pinpointing the development of doctor-patient communication skills beyond the 
academic setting. In addition, there is a need to gather information from dental school and 
orthodontic residency administrators regarding their willingness to include HPV in 
respective curricula, and to provide a directive for them to do so. An opportunity exists to 
contribute to public health efforts to increase HPV vaccination rates and decrease HPV-
related oropharyngeal cancers; an opportunity that must not be missed through targeted 
public health interventions informed by future studies. 
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	Table 1. Characteristics of orthodontist participants currently practicing in the state of Florida (N=119), 2017 
Characteristic 
Overall 
 
Willing to Provide HPV 
Educational Intervention  
Agree HPV is Within the Scope 
of Orthodontic Practice 
Frequency 
(Mean) 
Percent 
(SE) 
 Column % 
[Mean (SE)] P-Value  
Column % 
[Mean (SE)] P-Value 
         
Gender         
Female 43 36.75  25.6 0.81  15.5 0.53 
Male 74 63.25  42.7   30.2  
Age (years) (48.64) (1.19)      [48.6 (49.7)] < 0.01  [48.6 (48.9)] < 0.01 
Race         
    White 100 85.47  59.0 0.54  38.8 0.98 
Black or African American 4 3.42  1.7   1.7  
Asian 5 4.27  2.6   1.7  
Other 8 6.84  6.0   3.5  
Hispanic / Latino         
No 99 83.9  55.9 0.29  37.6 0.84 
Yes 19 16.1  12.7   7.7  
Graduation Year         
< 1970 1 0.85  0.9 0.83  0.9 0.85 
1970 - 1979 11 9.4  6.8   4.3  
1980 - 1989 20 17.09  13.7   6.0  
1990 - 1999 22 18.8  12.0   9.5  
2000 - 2010 32 27.35  18.0   12.9  
> 2010 31 26.5  18.0   12.1  
Years in Practice  (18.01) (1.23)  [18.0 (18.8)] < 0.01  [17.9 (17.8)] < 0.01 
Patients treated daily         
0-25 20 17.39  13.9 < 0.01  11.4 0.11 
26-50 35 30.43  20.9   14.9  
51-75 42 36.52  27.8   14.9  
76-100 15 13.04  3.5   2.6  
100+ 3 2.61  2.6   1.8  
Patients          
≤ 17 years of age (72.06) (1.25)  [72.1 (71.2)] < 0.01       [72.0 (70.8)] < 0.01 
≥ 18 years of age  (28.47) (1.36)  [28.5 (28.7)]        [28.5 (29.3)]  
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Table 1 (Continued)      
Characteristic 
Overall   Willing to Provide HPV Educational Intervention  
Agree HPV is Within the Scope 
of Orthodontic Practice 
Frequency 
(Mean) 
Percent 
(SE)  
Column % 
[Mean (SE)] P-Value  
Column % 
[Mean (SE)] P-Value 
         
Practice Setting         
Private practice 112 95.73  64.1 0.30  41.4 0.04 
University-based practice 4 3.42  3.4   3.5  
Public Health practice 1 0.85  0.9   0.9  
Practice Type         
Solo practice 87 74.36  48.7 0.26  34.5 0.76 
Group practice 30 25.64  19.7   11.2  
Practice Location          
Urban 106 92.17  64.4 0.38  41.7 0.96 
Rural 9 7.83  4.4   3.5  
HPV content during education          
Received instruction           
No 38 31.93  24.4 0.23  15.3 0.67 
Yes 81 68.07  44.5   30.5  
Encouraged to discuss/recommend vaccine         
No 106 89.08  58.8 0.05  39.8 0.54 
Yes 13 10.92  10.1   5.9  
HPV knowledge         
Self-rated knowledge         
None/limited 12 10.26  6.0 0.65  4.3 0.92 
Moderate 67 57.26  40.2   25.9  
Good 31 26.5  18.0   12.9  
Excellent 7 5.98  5.1   3.5  
Causes cancer in females         
Disagree 6 5.08  2.5 0.31  1.7 0.55 
Agree 112 94.92  66.1   43.6  
Causes cancer in males         
Disagree 24 20.34  11.0 0.09  6.0 0.07 
Agree 94 79.66  57.6   39.3  
Knowledge of disease transmission modes         
None/limited 12 10.08  8.4 0.43  3.4 0.77 
Moderate 58 48.74  31.1   22.0  
Good 38 31.93  21.9   16.1  
Excellent 11 9.24  7.6   4.2  
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Table 1 (Continued)         
Characteristic 
Overall   Willing to Provide HPV Educational Intervention  
Agree HPV is Within the Scope 
of Orthodontic Practice 
Frequency 
(Mean) 
Percent 
(SE)  
Column % 
[Mean (SE)] P-Value  
Column % 
[Mean (SE)] P-Value 
         
         
Sexually transmitted disease         
Disagree 8 6.84  6.8 0.05  4.3 0.30 
Agree 109 93.16  61.5   40.5  
Preventable disease          
Disagree 3 2.56  0.9 0.19  1.7 0.44 
Agree 114 97.44  67.5   43.1  
Self-rated knowledge of HPV vaccine         
None/Limited 14 11.76  9.2 0.58  5.1 0.76 
Moderate 51 42.86  26.9   20.3  
Good  41 34.45  24.4   14.4  
Excellent  13 10.92  8.4   5.9  
Self-rated knowledge of HPV vaccine         
None/limited 32 26.89  17.7 0.48  11.9 0.51 
Moderate 63 52.94  39.5   26.3  
Good 21 17.65  10.1   5.9  
Excellent 3 2.52  1.7   1.7  
Self-assessment regarding HPV-related 
material          
Additional knowledge needed about HPV 
prevention          
Disagree 17 14.41  5.9 0.01  5.1 0.33 
Agree 101 85.59  63.6   41.0  
Information on discussion skills needed          
Disagree 16 13.68  4.3 < 0.01  2.6 0.02 
Agree 101 86.32  65.8   44.0  
Information on vaccination administration 
needed          
Disagree 25 21.37  10.3 0.01  8.6 0.52 
Agree 92 78.63  58.1   37.1  
Patient referrals         
Know where to refer for HPV information         
No 51 42.86  32.8 0.12  19.5 0.96 
Yes 68 57.14  36.1   26.3  
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Table 1 (Continued)         
Characteristic 
Overall   Willing to Provide HPV Educational Intervention  
Agree HPV is Within the Scope 
of Orthodontic Practice 
Frequency 
(Mean) 
Percent 
(SE)  
Column % 
[Mean (SE)] P-Value  
Column % 
[Mean (SE)] P-Value 
         
Know where to refer for HPV vaccination         
No 40 33.61  25.2 0.31  15.3 0.95 
Yes 79 66.39  43.7   30.5  
Don't know where to refer for HPV vaccine         
Disagree 84 71.19  47.5 0.47  33.3 0.70 
Agree 34 28.81  21.2   12.0  
Medical referrals          
Physician's in my own referral network 1 0.84  0.0 0.08  0.0 0.17 
Refer patients to their primary care provider 107 89.92  63.9   44.1  
I do not usually refer for medical conditions 9 7.56  5.0   1.7  
Other 2 1.68  0.0   0.0  
Orthodontists responsible for patient health          
Disagree 8 6.72  1.7 0.01  0.9 0.05 
Agree 111 93.28  67.2   44.9  
HPV is within the scope of practice          
Disagree 64 54.24  28.0 < 0.01    
Agree 54 45.76  40.7     
HPV information currently provided          
Discussion         
No 114 96.61  66.1 0.18  42.7 0.03 
Yes 4 3.39  3.4   3.4  
Informational pamphlets         
No 119 100  68.9   45.8  
Educational video         
No 118 100  69.5   46.2  
Willing to discuss HPV with patients/parents         
Not willing 65 54.62  23.5 < 0.01  11.0 < 0.01 
Willing 54 45.38  45.4   34.8  
Willing to offer HPV informational pamphlet         
Not willing 38 31.93  0.8 < 0.01  5.1 < 0.01 
Willing 81 68.07  68.1   40.7  
Willing to offer HPV educational video         
Not willing 79 66.39  35.3 < 0.01  20.3 < 0.01 
Willing 40 33.61  33.6   25.4  
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Table 1 (Continued)         
Characteristic 
Overall   Willing to Provide HPV Educational Intervention  
Agree HPV is Within the Scope 
of Orthodontic Practice 
Frequency 
(Mean) 
Percent 
(SE)  
Column % 
[Mean (SE)] P-Value  
Column % 
[Mean (SE)] P-Value 
         
Willingness to offer an educational 
intervention (discussion, pamphlets, video)         
Not willing 37 31.09     5.1 < 0.01 
Willing 82 68.91     40.7  
Importance of HPV communication         
Unimportant 42 35.59  17.0 < 0.01  6.0 < 0.01 
Important 76 64.41  51.7   39.3  
Orthodontists’ comfort discussing HPV         
Disagree 71 60.17  35.6 0.01  16.2 < 0.01 
Agree 47 39.83  33.1   29.1  
Colleagues' perception of orthodontist 
improved          
Disagree 83 70.34  42.4 < 0.01  23.9 < 0.01 
Agree 35 29.66  26.3   21.4  
Acting in best interest of patient          
Disagree 21 17.65  5.9 < 0.01  2.5 < 0.01 
Agree 98 82.35  63.0   43.2  
Patients/parents amenable to HPV 
information          
Disagree 79 68.7  41.7 0.01  21.1 < 0.01 
Agree 36 31.3  27.0   23.7  
Patients' perception of orthodontist would 
improve         
Disagree 76 64.41  36.4 < 0.01  18.0 < 0.01 
Agree 42 35.59  32.2   27.4  
Patients/parents would be uncomfortable 
discussing HPV         
Disagree 29 25  23.3 < 0.01  21.7 < 0.01 
Agree 87 75  45.7   23.5  
Afraid of offending patients         
Disagree 57 48.31  37.3 0.05  29.1 < 0.01 
Agree 61 51.69  31.4   16.2  
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Table 1 (Continued) 
Characteristic 
Overall   Willing to Provide HPV Educational Intervention  
Agree HPV is Within the Scope 
of Orthodontic Practice 
Frequency 
(Mean) 
Percent 
(SE)  
Column % 
[Mean (SE)] P-Value  
Column % 
[Mean (SE)] P-Value 
         
Providing HPV information          
Is orthodontist's responsibility          
Disagree 80 68.38  41.9 0.01  21.6 < 0.01 
Agree 37 31.62  26.5   23.3  
May be delegated to chairside assistant          
Disagree 55 47.41  28.5 0.08  20.0 0.60 
Agree 61 52.59  39.7   24.4  
May be delegated to treatment 
coordinator/office manager          
Disagree 56 48.28  27.6 0.01  18.3 0.20 
Agree 60 51.72  40.5   26.1  
Time willing to spend providing HPV 
information         
Not willing 35 29.91  7.7 < 0.01  3.5 < 0.01 
Less than 1 minute 22 18.8  13.7   6.0  
1-2 minutes 29 24.79  22.2   13.8  
3-4 minutes 22 18.8  17.1   14.7  
5 minutes or more 9 7.69  7.7   6.9  
Orthodontists’ responses about HPV vaccine          
Vaccination of children at 11-12 years old          
Unimportant 22 18.64  9.3 0.03  4.3 0.01 
Important 96 81.36  60.2   41.9  
Willing to deliver HPV vaccine to patients*         
Not willing 88 73.95  46.2 0.01  29.7 0.03 
Willing 31 26.05  22.7   16.1  
Colleagues' perception of orthodontist 
improved          
Disagree 86 74.14  45.7 0.01  25.2 < 0.01 
Agree 30 25.86  22.4   19.1  
Patients' perception of orthodontist 
improved         
Disagree 83 72.81  43.0 < 0.01  23.9 < 0.01 
Agree 31 27.19  25.4   20.4  
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Table 1 (Continued)         
Characteristic 
Overall   Willing to Provide HPV Educational Intervention  
Agree HPV is Within the Scope 
of Orthodontic Practice 
Frequency 
(Mean) 
Percent 
(SE)  
Column % 
[Mean (SE)] P-Value  
Column % 
[Mean (SE)] P-Value 
         
Acting in best interest of patient          
Disagree 33 28.45  15.5 0.05  6.1 < 0.01 
Agree 83 71.55  52.6   38.3  
Negative reactions from patients          
Disagree 44 38.26  30.4 0.03  21.9 0.03 
Agree 71 61.74  37.4   21.9  
Acting in best interest of patient          
Disagree 33 28.45  15.5 0.05  6.1 < 0.01 
Agree 83 71.55  52.6   38.3  
Expect reimbursement for educational 
intervention         
Disagree 96 80.67  56.3 0.67  38.1 0.48 
Agree 23 19.33  12.6   7.6  
Would provide educational intervention 
without reimbursement          
Disagree 42 35.59  18.6 < 0.01  9.4 < 0.01 
Agree 76 64.41  50.9   36.8  
Survey response by:         
Hard Copy Survey response 76 63.87  42.9 0.57  25.4 0.07 
Web-based Survey Response 43 36.13  26.1   20.3  
Integrated Behavior Model (IBM) Constructs         
Perceived Norm (Injunctive Norm) 0.00 0.19  [0.58, (0.24)] <0.01  [1.18, (0.32)] <0.01 
Self-Rated Knowledge 0.00 0.16  [-0.02, (0.19)] 1.0  [0.03, (0.23)] 0.47 
Personal Agency (Self-Efficacy) 0.00 0.15  [-0.11, (0.18)] 0.27  [0.05, (0.21)] 0.91 
Salience 0.00 0.13  [-0.16, (0.16)] 0.03  [-0.39, (0.18)] 0.01 
Personal Agency (Perceived Control) 0.00 0.14 [ [0.62, (0.09)] <0.01  [0.58, (0.13)] <0.01 
Environmental Constraints  0.00 0.13  [0.25, (0.15)] 0.01  [0.44, (0.18)] 0.01 
         
This item was prefaced by the hypothetical: “If administration of vaccines were considered within the scope of dental practice…” 
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Table 2 – Principal Component Analysis (N=119) 
Variables 
Components 
Injunctive 
Norm*  
Self-rated 
Knowledge 
Self-
Efficacy†  Salience 
Perceived 
Control†  
Environmental 
Constraints 
Colleagues' perception of orthodontist improved (HPV) 0.28      
Colleagues' perception of orthodontist improved (vaccine) 0.28      
Discuss HPV with patients/parents (willing) 0.25      
Patients' perception of orthodontist improved (vaccine) 0.30      
Patients' perception of orthodontist improved (HPV) 0.30      
Patients/parents uncomfortable discussing HPV -0.27      
Self-rated knowledge of routine childhood vaccines  0.30     
Self-rated knowledge of HPV vaccine  0.32     
Additional knowledge required  -0.28     
Modes of disease transmission  0.37     
Self-rated knowledge (HPV)  0.34     
Where to refer for HPV information   -0.43    
Where to refer for HPV vaccination   -0.42    
Don't know where to refer for HPV vaccine   0.36    
Encouraged to discuss/recommend vaccine    0.37   
Afraid of offending patients    0.31   
Negative reactions from patients (vaccine)     0.33   
Medical referrals    0.35   
May be Delegated to treatment coordinator/office manager 
(HPV)    -0.25   
Importance of HPV communication     0.27  
Additional discussion skills required (HPV)     0.28  
Additional vaccination information required     0.26  
Willing to give HPV informational pamphlet     0.27  
Orthodontists responsible for patient health     0.25  
Received instruction       0.26 
Preventable disease      0.28 
Expect reimbursement for educational intervention      0.47 
Would provide educational intervention without reimbursement      -0.37 
* A subcategory of Perceived Norm 
† A subcategory of Personal Agency       
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Table 3 – Logistic regression results for the dependent variable “Willing to provide HPV educational 
intervention” (N=119), 2017 
 Willing vs. unwilling to provide HPV educational 
intervention  
Model 
Effect  
p-value 
AORa (95% CI) p-value 
    
Gender 0.111   
Female  1.00 … 
Male  4.29 (0.72, 25.71) 0.111 
Age 0.021 1.12 (1.02, 1.23) 0.021 
Race 0.287   
White  1.00 … 
Black or African American  1.07 (0.06, 18.09) 0.960 
Asian  0.30 (0.027, 3.29) 0.322 
Other  0.21 (0.01, 8.34) 0.406 
Hispanic / Latino 0.413   
No  1.00 … 
Yes  4.84 (0.11, 210.78) 0.413 
Practice Location  0.329   
Urban  1.00 … 
Rural  2.52 (0.39, 16.19) 0.329 
Practice Type 0.481   
Solo practice  1.00 … 
Group practice  2.26 (0.23, 21.91) 0.481 
Time willing to spend providing HPV 
information  0.087   
Not willing  1.00 … 
Less than 1 minute  131.40 (6.66, 2592.76) 0.001 
1-2 minutes  371.81 (6.28, 22011.95) 0.004 
3-4 minutes  175.57 (6.86, 4495.87) 0.002 
5 minutes or more  … … 
Providing HPV information may be delegated 
to chairside assistant 0.172   
Disagree  1.00 … 
Agree  1.42 (0.86, 2.34) 0.172 
HPV causes cancer in females 0.005   
Disagree  1.00 … 
Agree  4.07 (1.51, 10.94) 0.005 
Personal Agency    
Perceived Control  0.033 2.03 (1.06, 3.90) 0.033 
Self-Efficacy 0.059 5.40 (0.94, 31.16) 0.059 
Salience  0.008 3.09 (1.35, 7.09) 0.008 
    
a. AOR – Adjusted Odds Ratio 
b. Sociodemographic variables forced into the model as covariates: Gender, Age, Race, Hispanic/Latino, Practice 
Location, and Practice Type 
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a. AOR – Adjusted Odds Ratio 
b. Sociodemographic variables forced into the model as covariates: Gender, Age, Race, Hispanic/Latino,  
    Practice Location, Practice Type  
Table 4 – Logistic regression results for the dependent variable “HPV is Within Scope of 
Orthodontic Practice” (N=119), 2017 
 Agree vs. disagree that HPV is Within Scope of 
Orthodontic Practice 
Model 
Effect    
p-value 
AORa  (95% CI) p-value 
    
Gender 0.242   
Female  1.00 … 
Male  0.49 (0.15, 1.63) 0.242 
Age 0.114 0.96 (0.92, 1.01) 0.114 
Race 0.464   
White  1.00 … 
Black or African American  0.53 (0.06, 4.42) 0.554 
Asian  1.60 (0.09, 29.48) 0.751 
Other  0.41 (0.05, 3.69) 0.423 
Hispanic / Latino 0.764   
No  1.00 … 
Yes  0.77 (0.14, 4.22) 0.764 
Practice Location  0.183   
Urban  1.00 … 
Rural  3.82 (0.53, 27.38) 0.183 
Practice Type 0.286   
Solo practice  1.00 … 
Group practice  0.50 (0.14, 1.78) 0.286 
Time willing to spend providing HPV 
information  0.013   
Not willing  1.00 … 
Less than 1 minute  7.55 (1.09, 52.33) 0.041 
1-2 minutes  21.20 (3.44, 130.52) 0.001 
3-4 minutes  41.05 (6.04, 279.12) 0.000 
5 minutes or more  18.92 (0.95, 378.13) 0.054 
Personal Agency    
Perceived Control  0.182 1.53 (0.82, 2.85) 0.182 
Salience 0.151 0.72 (0.46, 1.13) 0.151 
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FOCUS GROUP QUESTIONS 	
	
Experiential	Attitude			How	do	you	feel	about	the	idea	of	providing	HPV	educational	intervention	to	your	patients	and	their	parents?			What	do	you	like/dislike	about	the	idea	of	providing	HPV	educational	intervention	to	your	patients	and	their	parents?		What	would	you	enjoy/hate	about	providing	HPV	educational	intervention	to	your	patients	and	their	parents?		
Instrumental	Attitude		What	are	some	of	the	advantages	of	providing	HPV	educational	intervention	to	your	patients	and	their	parents?		What	are	some	of	the	benefits	that	might	result	from	providing	HPV	educational	intervention	to	your	patients	and	their	parents?		What	are	some	of	the	disadvantages	of	providing	HPV	educational	intervention	to	your	patients	and	their	parents?			What	are	the	negative	effects	that	might	result	from	providing	HPV	educational	intervention	to	your	patients	and	their	parents?		
Normative	Influence			Who	would	support	your	decision	to	provide	HPV	educational	intervention	to	your	patients	and	their	parents?			Who	would	be	against	your	decision	to	provide	HPV	educational	intervention	to	your	patients	and	their	parents?		If	you	were	to	consider	providing	an	HPV	educational	intervention	for	your	patients	and	their	parents,	is	there	someone	who’s	opinion	would	be	instrumental	to	you	in	your	decision?		
Perceived	Control		What	things	would	make	it	easy	for	you	to	provide	HPV	educational	intervention	to	your	patients	and	their	parents?		What	things	would	make	it	hard	for	you	to	provide	educational	intervention	to	your	patients	and	their	parents?		
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Self-Efficacy			If	you	want	to	provide	HPV	educational	intervention	to	your	patients	and	their	parents,	how	certain	are	you	that	you	can?		What	kinds	of	things	would	help	you	overcome	any	barriers	to	providing	HPV	educational	intervention	to	your	patients	and	their	parents?		
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Participation Letter  
Title of Study: Florida Orthodontists' willingness to provide Human Papilloma Virus 
(HPV) Educational Intervention Principal	investigator	 	 	 	 Co-investigator	Marc	Weber,	D.D.S.	 	 	 	 	 Richard	Singer,	D.M.D.,	M.S.	901	SE	2nd	Court	#2		 	 	 	 	 3301	College	Avenue		Fort	Lauderdale,	FL	33301	 	 	 	 Fort	Lauderdale,	FL	33314	(704)	491-8918	 	 	 	 	 (954)	262-1610	
 
For questions/concerns about your research rights, contact: 
Human Research Oversight Board (Institutional Review Board or IRB)  
Nova Southeastern University 
(954) 262-5369 / Toll Free: 866-499-0790 
IRB@nsu.nova.edu 	 	 	 	 	
Description of Study: You are invited to participate in a research study. The purpose of 
this study will focus on identifying the determinants of Florida Orthodontists’ willingness 
to provide information regarding the Human Papilloma Virus (HPV) and/or HPV 
vaccinations to adolescent patients and their parents.  	
We are inviting you to participate because you are an orthodontist currently practicing in 
the state of Florida. Participants include American Association of Orthodontists (AAO) 
members recruited from the AAO member directory and non-AAO member orthodontists 
recruited from the Florida Yellow Pages. The results of this study may be used to inform 
possible future public health interventions aimed towards increasing acceptance of the 
HPV vaccination and thereby reducing the prevalence of both HPV infections and 
associated cancers. There will be between 400 to 450 participants in this research study.  
 
You are asked to complete a self-administered 10 to 15-minute electronic survey housed 
on the secure, HIPAA-compliant NSU REDCap web site. The survey includes multiple 
choice and fill in the blank (drop-down list) items, including demographic information. 
After you complete the survey instrument, your responses will be de-identified and 
analyzed. 
 
Risks/Benefits to the Participant: There is minimal risk to you as a participant. The 
greatest potential risk may be compromised confidentiality and anonymity. However, 
every reasonable attempt has been designed into the study administration protocols to 
protect your confidentiality and anonymity, including use of a secure HIPAA-complaint 
server for data acquisition and storage. If you have any questions about the research, your 
research rights, or have a research-related injury, please contact Dr. Marc Weber or Dr. 
Richard Singer at the phone numbers indicated above. You may also contact the IRB at 
the numbers indicated above with questions as to your research rights. There are no direct 
benefits for your participation in this study.  	
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Cost	and	Payments	to	the	Participant:	There	are	no	costs	to	you	and	no	monetary	compensation	for	participating	in	this	study,	however,	participants	who	complete	the	survey	will	be	provided	entry	into	a	drawing	for	an	Apple	iWatch	in	appreciation	of	their	time	and	contribution	to	our	research.		
Confidentiality:	All	information	obtained	in	this	study	is	strictly	confidential,	unless	disclosure	is	required	by	law.	Data	collected	using	the	secured	web	site,	REDCap,	will	be	automatically	de-identified	to	ensure	anonymity	and	confidentiality	of	participants.	All	participant	email	addresses	and	contact	information	will	be	disassociated	from	survey	response	data	and	stored	on	a	separate	password	protected	university	server.	All	data	acquired	during	this	research	will	be	deleted	after	36	months	from	the	conclusion	of	the	study	as	required	by	the	IRB.	The	IRB,	regulatory	agencies,	and	Dr.	Weber	or	Dr.	Singer	may	review	research	records.		
Participant’s	Right	to	Withdraw	from	the	Study:	Your	participation	is	voluntary;	you	are	free	to	refuse	to	participate	in	or	withdraw	from	this	study	at	any	time	without	penalty.	If	you	do	not	want	to	continue,	you	can	simply	leave	this	website.	If	you	do	not	click	on	the	submit	button	at	the	end	of	the	survey,	your	answers	and	participation	will	not	be	recorded.	If	you	choose	to	withdraw	after	completion	of	the	survey,	any	information	collected	from	you	before	the	date	you	leave	the	study	will	be	kept	in	the	research	records	for	36	months	from	the	conclusion	of	the	study,	but	you	may	request	that	it	not	be	used	by	contacting	the	principal	investigator	in	a	timely	manner.		
I	have	read	this	letter	and	I	fully	understand	the	contents	of	this	document	and	
voluntarily	consent	to	participate.	All	of	my	questions	concerning	this	
research	have	been	answered.	If	I	have	any	questions	in	the	future	about	this	
study,	the	investigator	listed	above	or	his	staff	will	answer	them.		
 
I understand that the completion of this questionnaire implies my consent to 
participate in this study.  	
 I	have	read	and	understand	the	informed	consent	above:			YES											NO	
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HPV	SURVEY	INSTRUMENT	
		1.	Study	ID			2.	I	understand	that	the	completion	of	this	questionnaire	implies	my	consent	to	participate	in	this	study.		
I	understand			3.	Do	you	currently	offer	any	of	the	following	Human	Papilloma	Virus	(HPV)	educational	interventions	to	your	patients?		
 
 						4.	If	you	do	not	currently	offer	these	interventions,	how	willing	would	you	be	to	offer	it	as	part	of	your	practice	within	the	next	year?			
		5.	If	administration	of	vaccinations	were	considered	to	be	within	the	scope	of	dental	practice…			
			
  
1Yes 0No  
a HPV informational pamphlets   
b Discuss HPV with parents/patients    
c HPV educational video   
  Willingness to Offer 
  0 not willing 1 somewhat unwilling 2 somewhat willing 3 very willing 
a HPV informational pamphlets     
b Discuss HPV with 
parents/patients  
    
c HPV educational video     
  Willingness to Administer the HPV vaccine 
 0 not willing 1 somewhat unwilling 
2 somewhat 
willing 3 very willing 
a How willing would you be to deliver the 
HPV vaccine to your patients? 
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6.	The	following	concern	HPV	knowledge	acquired	during	your	professional	education.		
  1 Yes 0 No 
a Did you learn about HPV during your professional education?   
b Were you encouraged to discuss HPV with your patients during your 
professional education? 
  
c Were you encouraged to recommend the HPV vaccine during your 
professional education? 
  	7.	How	would	you	rate	your	clinical	knowledge	of	the	following?		
  0 
none/limited 1 moderate 2 good 
3 
excellent 
a Human Papilloma Virus (HPV)      
b HPV vaccinations (efficacy, 
associated risks, availability)  
    
c HPV modes of transmission      
d Routine childhood vaccines (eg., 
MMR, DTaP, Polio)  
    		8.	Where	is	the	one	place	where	you	most	often	refer	patients	for	follow-up	of	medical	conditions?	(please	select	one	response)		
Physician’s	in	my	own	referral	network	
 Refer	patients	back	to	their	own	primary	care	provider		
I	do	not	routinely	make	referrals	for	medical	conditions	
Other		9.	Do	you	know	a	place	where	you	can	refer	a	patient	for	the	following?																
  1 Yes 0 No 
a HPV educational information   
b HPV vaccination   
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10.	How	much	do	you	agree	or	disagree	with	the	following	statements?	
		11.	Please	indicate	how	much	you	agree	or	disagree	with	each	of	the	following	statements:	If	I	offered	HPV	educational	intervention	to	my	patients…		 	 	 0 strongly 
disagree 1 disagree 2 agree 
3 strongly 
agree 
a I would feel that I am acting in the best 
interest of the patient 
	 	 	 	
b My colleagues’ perception of me as an 
orthodontist would improve 
	 	 	 	
c My patients’ perception of me as an 
orthodontist would improve 
	 	 	 	
d I would be afraid I would offend my 
patients  
	 	 	 		12.	If	you	were	to	contribute	to	a	public	health	effort	aimed	at	increasing	the	HPV	vaccination	rates	among	adolescent	patients,	please	answer	how	much	you	agree	or	disagree	with	the	following	statements.			 	 	 0 strongly 
disagree 
1 disagree 2 agree 
3 
strongly 
agree 
a I need additional knowledge about HPV 
prevention  
	 	 	 	
b I don’t know where to refer patients for the 
HPV vaccine  
	 	 	 	
c I need information about HPV vaccine 
administration 
	 	 	 	
d I would offer HPV educational intervention 
even if third party reimbursement was not 
available 
	 	 	 	
e I need information on how to discuss HPV 
effectively with my patients 
	 	 	 	
f Orthodontists, as dentists, have 
responsibilities for overall patient health and 
not just health of the oral cavity 
	 	 	 	
			
	 	 0 strongly 
disagree 1 disagree 2 agree 
3 strongly 
agree 
a HPV is a sexually transmitted 
disease (STD) 
	 	 	 	
b HPV is preventable  	 	 	 	
c HPV causes cancer in females 	 	 	 	
d HPV causes cancer in males 	 	 	 	
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13.	Regarding	the	possibility	of	offering	HPV	educational	intervention	in	your	practice,	how	much	do	you	agree	or	disagree	with	the	following	statements?		 	 	 0 strongly 
disagree 
1 
disagree 2 agree 
3 strongly 
agree 
a My patients and/or their parents are amenable 
to HPV educational intervention in the 
orthodontic setting 
	 	 	 	
b It would make my patients and/or their 
parents uncomfortable if I discussed HPV 
	 	 	 	
c I would feel comfortable talking with my 
patients and/or their parents about HPV 
	 	 	 	
d HPV is out of the scope of practice for an 
orthodontist 
	 	 	 	
e I expect reimbursement for my HPV 
educational intervention 
	 	 	 			14.	How	important	do	you	regard	each	of	the	following?	
		15.	Please	indicate	how	much	you	agree	or	disagree	with	each	of	the	following	statements.	If	I	offered	the	HPV	vaccine	to	my	patients…		 	 	 0 strongly 
disagree 1 disagree 2 agree 
3 strongly 
agree 
a I would feel that I am acting in the best 
interest of the patient 
	 	 	 	
b My colleagues’ perception of me as an 
orthodontist would improve 
	 	 	 	
c My patients’ perception of me as an 
orthodontist would improve 
	 	 	 	
d I would be concerned about negative 
reactions from my patients 
	 	 	 	
	
	
	
			
  
0 not 
important at 
all 
1 somewhat 
unimporta
nt 
2 
somewha
t 
importan
t 
3 very 
important 
a Communication with your patients and 
their parents regarding HPV 
    
b Vaccination of children between the 
ages of 11 and 12 years for HPV  
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16.	Are	you	Hispanic	/	Latino?		
 Yes	
No			17.	What	is	your	gender?		
Male	
 Female	
Other			18.	What	is	your	race?		
White		
 Black	or	African	American			
Asian		
American	Indian	or	Alaska	Native		
Native	Hawaiian	or	Pacific	Islander		
Other				19.	What	is	your	age	(years)?					20.	What	year	did	you	graduate	from	your	Postgraduate	Orthodontic	Residency	Program?					21.	How	many	years	have	you	practiced	Orthodontics	exclusively?					
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22.	Which	ONE	of	the	following	geographic	descriptors	best	describes	your	PRIMARY	current	practice?		
Urban		
 Rural				23.	Which	ONE	of	the	following	structural	descriptors	best	describes	your	PRIMARY	current	practice?		
Solo	practice	
 Group	practice		24.	Which	ONE	of	the	following	settings	best	describes	your	PRIMARY	current	practice?		
			Private	practice	
 			University-based	practice	
Public	health	practice		25.	Please	approximate	the	percent	of	the	patients	in	your	office	that	fall	within	the	following	age	categories	(Please	respond	by	entering	percentages	between:	0	–	100%).		 		 Ages	 Percent	(%)	a	 17	years	of	age	or	younger	 	 	 	b	 18	years	of	age	or	older	 	 	 	 			26.	Which	one	response	best	describes	the	number	of	patients	you	see	in	your	office	daily?		
0-25		
 26-50		
51-75		
76-100
			100+	
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27.	How	much	office	time	are	you	willing	to	spend	to	provide	an	HPV	educational	intervention	to	your	patients?		
not	willing			
 less	than	1	minute		
1-2	minutes		
3-4	minutes	
			5	minutes	or	more	
 		28.	Please	indicate	how	much	you	agree	or	disagree	with	the	following	statements	regarding	the	delivery	of	HPV	educational	intervention	to	your	patients?			 	 0 strongly 
disagree 
1 
disagree 2 agree 
3 
strongly 
agree 
a It is the responsibility of the orthodontist to 
deliver the educational intervention 
personally 
	 	 	 	
b Delivering educational intervention can be 
delegated to a chairside assistant 
	 	 	 	
c Delivering educational intervention can be 
delegated to a treatment coordinator and/or 
office manager 
	 	 	 	
			29.	Do	you	have	any	comments	on	providing	patients	with	HPV	education,	HPV	vaccination	referrals,	availability	of	training	materials,	and/or	other	chairside	medical	screenings	in	the	orthodontic	care	setting?	Please	let	us	know	below.	
______________________________________________________________________________________ 
______________________________________________________________________________________ 
______________________________________________________________________________________ 
______________________________________________________________________________________ 
______________________________________________________________________________________
______________________________________________________________________________________ 
______________________________________________________________________________________ 
______________________________________________________________________________________ 
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